SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group (NBIS) is trending as a critical local council vote unfolds on a massive AI data center project in Independence, Missouri, igniting intense community debate over its substantial economic prospects versus local concerns, while market sentiment also contends with broader sector volatility and geopolitical tensions impacting AI infrastructure plays.

Indonesia Energy Corp. Ltd. operates as an oil and gas, exploration, and production company. It engages in oil and gas assets portfolio with a mix between medium-sized producing blocks and exploration blocks with significant resources. Its portfolio includes Kruh, Citarum, and Rangkas Area. The company was founded by James J. Huang and Wirawan Jusuf in 2014 and is headquartered in Jakarta, Indonesia.

Indonesia Energy Corp Ltd

Indonesia Energy Corp Ltd (INDO) is trending as escalating geopolitical tensions in the Middle East, particularly concerns around the Strait of Hormuz and broader oil supply, fuel significant bullish sentiment across the energy sector. The community is actively discussing INDO's potential for a substantial rally and short squeeze, anticipating higher oil prices to persist for weeks.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is surging amid institutional investment, notably a hedge fund stake, and growing recognition from partners like Quantum Computing and Sivers, fueling community excitement over its disruptive optical interconnect technology crucial for scaling AI infrastructure and a forecasted strong revenue ramp.

Battalion Oil Corp. engages in the acquisition, production, exploration, and development of liquids-rich oil and natural gas assets in the Delaware Basin. The company was founded in 1987 and is headquartered in Houston, TX.

Battalion Oil Corp - Ordinary Shares (New)

Battalion Oil (BATL) is seeing extreme trading volume and a rapid price increase, driven by escalating geopolitical tensions in the Middle East that are propelling oil prices higher. The community is buzzing about a potential short squeeze, fueled by reports of high borrowing costs and a scarcity of shares available for shorting.

AeroVironment, Inc. engages in the design, development, and production of multi-domain robotic systems and related services for government agencies and businesses. It operates through the following business segments: UnCrewed Systems, Loitering Munitions Systems, and MacCready Work. The UnCrewed Systems segment focuses primarily on small UAS products designed to operate reliably at lower altitudes in a wide range of environmental conditions. The Loitering Munitions Systems segment focuses primarily on tube-launched aircraft that deploy with the push of a button, fly at higher speeds than small UAS products, and perform either effects delivery or reconnaissance missions, and related support services including training, spare parts, product repair, and product replacement. The MacCready Works segment focuses on customer-funded research and development in the areas of HAPS, robotics, sensors, software analytics, data intelligence, and connectivity. The company was founded by Paul B. MacCready, Jr. in July 1971 and is headquartered in Arlington, VA.

AeroVironment Inc.

AeroVironment is trending after a Raymond James downgrade to Underperform, citing uncertainty around the Space Force's SCAR program, its largest contract, which triggered a sharp intraday decline. The community is actively debating whether the sell-off is an overreaction and market manipulation or a legitimate concern for the defense drone leader.

MongoDB, Inc. engages in the development and provision of a general-purpose database platform. The firm's products include MongoDB Enterprise Advanced, MongoDB Atlas, and Community Server. It also offers professional services including consulting and training. The company was founded by Eliot Horowitz, Dwight A. Merriman, Kevin P. Ryan, and Geir Magnusson Jr. in November 2007 and is headquartered in New York, NY.

MongoDB Inc - Ordinary Shares - Class A

MongoDB Inc

MongoDB is trending after its recent earnings report, which, despite strong performance, included weaker-than-expected forward guidance and leadership changes, triggering a sharp stock decline. The community is split between those who view the pullback as an overblown reaction and a buying opportunity, and others who believe the valuation adjustment is justified.

Hydrograph Clean Power, Inc. engages in the research, development, marketing and commercialization of patented technology to produce pristine graphene, graphene derivatives and services. The company was founded by Harold Charles Davidson on June 26, 2017 and is headquartered in Vancouver, Canada.

Hydrograph Clean Power Inc

Hydrograph Clean Power (HGRAF) is surging after securing regulatory clearances from the US EPA, UK, and EU for commercial graphene sales, removing a major bottleneck and fueling intense community discussion about its high-purity material and anticipated contracts. The recent oversubscribed capital raise further signals market confidence in its path to industrial execution and rapid expansion.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group Inc. is trending after announcing record annual revenue for 2025 and a major profitability turnaround, alongside a significant AI infrastructure pipeline and a recent MoU in Saudi Arabia. The community is actively debating whether these strong fundamentals position the deeply undervalued stock for a re-rating or if past skepticism and ongoing short interest will continue to weigh on its price.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is trending as the FDA lifted the clinical hold on its MAGNITUDE-2 Phase 3 trial, with the patient death now attributed to an ulcer rather than the CRISPR-based therapy. The community is actively discussing a significant short squeeze potential due to high short interest, with many seeing the stock as undervalued and this development as a positive signal for the broader gene-editing industry.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is trending after revealing Oracle as the previously undisclosed hyperscaler tenant for its Polaris Forge 2 campus, with a $2.15 billion debt offering announced to fund the facility's expansion. The community is actively discussing the strategic importance of this major client win and anticipating further expansion at the campus amid booming demand for AI data center infrastructure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Syndax Pharmaceuticals (NASDAQ:SNDX) Given New $57.00 Price Target at Citigroup

Citigroup increased their target price on Syndax Pharmaceuticals from $51.00 to $57.00 and gave the company a "buy" rating in a report on Monday...

Syndax Pharmaceuticals (NASDAQ:SNDX) Rating Lowered to Sell at Wall Street Zen

Wall Street Zen lowered Syndax Pharmaceuticals from a "hold" rating to a "sell" rating in a research report on Saturday...

Syndax Pharmaceuticals Q4 Earnings Call Highlights

Syndax Pharmaceuticals (NASDAQ:SNDX) executives highlighted a transformational year in 2025 during the company's fourth-quarter earnings call, pointing to momentum from two commercial launches...

Syndax Pharmaceuticals (NASDAQ:SNDX) Announces Quarterly Earnings Results, Misses Expectations By $0.12 EPS

Syndax Pharmaceuticals (NASDAQ:SNDX - Get Free Report) issued its quarterly earnings results on Thursday. The company reported ($0.78) earnings per share (EPS) for the quarter, missing analysts...

Syndax Pharmaceuticals (SNDX) Reports Q4 Loss, Tops Revenue Estimates

Syndax (SNDX) delivered earnings and revenue surprises of -21.88% and +10.21%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Insights into Syndax Pharmaceuticals Q4 Earnings

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX - Get Free Report) has earned an average recommendation of "Moderate Buy" from the twelve analysts that are covering the stock, Marketbeat.com reports. One...

Syndax Pharmaceuticals (SNDX) Projected to Post Earnings on Monday

Syndax Pharmaceuticals (NASDAQ:SNDX) will be releasing its Q4 2025 earnings before the market opens on Monday, March 2. (View Earnings Report at...

Aberdeen Group plc Grows Position in Syndax Pharmaceuticals, Inc. $SNDX

Aberdeen Group plc raised its stake in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX - Free Report) by 22.9% in the third quarter, according to the company in its most recent disclosure with the...

Syndax Pharmaceuticals Highlights Revuforj, Niktimvo Sales Surge and 2026 Milestones at Guggenheim Conf

Syndax Pharmaceuticals (NASDAQ:SNDX) executives told investors at a Guggenheim biotech conference that the company entered 2026 with what CEO Michael Metzger called a fantastic start, pointing to...

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.

Syndax Pharmaceuticals Inc

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $MDB earnings today?

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.55	--	--	N/A
Q4 '25	-$0.58	-$0.78	-33.55%	MISSED
Q3 '25	-$0.72	-$0.70	3.38%	BEAT
Q2 '25	-$1.02	-$0.83	18.32%	BEAT
Q1 '25	-$1.26	-$0.98	22.42%	BEAT

SNDX
Syndax Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q4 '25

Historical Earnings

Latest SNDX News

SNDXSyndax Pharmaceuticals Inc